Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2002

View Archived Issues

Bay-43-9006 discussed at AACR

Results from phase II study of IPL-576092 in asthma

Prefilled syringe presentation of Copaxone launched

Periostat approved in Austria and Finland

Pan-caspase inhibitor protects against renal ischemia/reperfusion injury

Blockade of VLA-4 together with immunosuppression may help prevent transplant vasculopathy

Data from preclinical research confirm the potential of AVI-4557 for metabolic redirection

ECCMID presentations highlight the promise of PLD-118, a novel antifungal agent

Complement inhibitor GAS-914 may protect against cytotoxic injury in xenotransplantation

Interim phase II results for ISAtx-247 in renal transplantation

Good correlation between duration of bacterial exposure to and in vivo efficacy of SB-264128

ECCMID news: antimicrobial activity and effects on intestinal microflora reported for BMS-284756

Novavax withdraws NDA for Estrasorb with plans to resubmit

Successful phase II results lead to expanded development of pralnacasan

BioCryst updates first-quarter progress

MediGene submits MAA in Germany for Eligard 22.5 mg

Altana and Pharmacia to codevelop and comarket roflumilast for respiratory conditions

Chromos and MorphoGen collaborate on stem cell technologies

Pennsaid receives approval in Europe, to be distributed in Benelux by Tramedico

Peptide derG provides protection against malaria, herpes and cancer

Idec extends IDEC-152 collaboration with Seikagaku

Factor Xa inhibitors and their use in thrombotic disorders

Pyridazine compounds claimed by Biovitrum for diabetes Rx

Pharmacia presents new integrin antagonists in patent literature

Immunomodulating and neurotrophic effects reported for 1-oxorapamycins

New 5-HT1A ligands and monoamine reuptake inhibitors and their therapeutic applications

Advanced Medicine patents sodium channel modulators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...